A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT

Clinical trial NCT07387367 · RECRUITING

Trial details

NCT number: NCT07387367
Sponsor: SymBio Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Adenovirus Infections

Start date: 2026-03-17
Primary completion: 2028-01-31
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.